| Autor: |
D. B. Giller, S. S. Saenko, A. N. Gerasimov, G. V. Shcherbakova, A. A. Popova, V. A. Basangova, A. N. Ilyukhin, O. Sh. Kesaev, E. A. Bagdasaryan |
| Jazyk: |
ruština |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Инновационная медицина Кубани, Vol 0, Iss 3, Pp 8-15 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2541-9897 |
| DOI: |
10.35401/2541-9897-2024-9-3-8-15 |
| Popis: |
Objective: To study and compare surgical risks and immediate effectiveness of surgical treatment in patients with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB).Materials and methods: We examined immediate treatment outcomes of 1180 patients who underwent surgery for destructive MDRTB, pre-XDR-TB, and XDR-TB between 2011 and 2023. The patients were grouped: group 1 for patients with MDR-TB (744 cases) and group 2 for patients with pre-XDR-TB and XDR-TB (436 cases). Moreover, patients were further subdivided based on the extent of surgery.Results: The complete clinical response, ie, cavity closure and elimination of bacilli (CV-, MBT-), was achieved in all 405 patients who underwent radical surgery, in 673 (97.1%) of 694 patients who underwent semiradical surgery, and only in 10 (12.3%) of 81 patients who underwent palliative surgery.Conclusions: The immediate outcomes of surgical treatment for MDR-TB were superior in all parameters compared with those for pre-XDR-TB and XDR-TB; however, we found no significant differences when we evaluated treatment effectiveness in patients who underwent radical and semiradical surgery. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
